A Clinical Analysis of Extrapulmonary Complications in Novel Coronavirus Pneumonia Patients

Figures & data

Table 1 Incidence of Extrapulmonary Complications in 152 COVID-19 Patients

Damaged System	The Number of Cases	Proportion (%)	The number of Gender Cases^a		Average Age (Years Old)^b
Digestive system	98	64.47	Male	58	43±0.5
			Female	40
Cardiovascular system	43	28.29	Male	25	56±0.5
			Female	18
Urinary system	32	21.05	Male	15	45±0.5
			Female	17
Nervous system	25	16.45	Male	12	39±0.5
			Female	13

Notes: ^aThere is no significant difference in the ratio of male to female in various extrapulmonary complications X²=2.193, P>0.05; ^bThe difference in age among patients with various extrapulmonary complications was statistically significant F=67.382, P<0.05.

Table 2 Comparison of Clinical Curative Effect Among Patients without Complications, Patients with Extrapulmonary Complications and Patients with Chronic Diseases

	Proportion (%)	Number of Patients with Excellent Effect	Proportion (%)	Number of Patients with Effective Outcomes	Proportion (%)	Number of Patients with Ineffective Outcome	Proportion (%)
Patients without complications	251	198	78.88	53	21.12	0	0
Patients with complications	152	93	61.18	55	36.18	4	2.63
Patients with chronic disease	97	38	39.18	44	45.36	15	15.46

Note: Comparison among groups: X²=73.795, P<0.05.

Table 3 Comparison of Age and Gender Among Patients with Extrapulmonary Complications in Different Therapeutic Groups

	The Number of Cases	Proportion (%)	Average Age^a (Years Old)	The Number of Gender Cases^b		Ratio of Male-to-Female(%)
Excellent	93	61.18	34±0.5	Male	50	53.76
				Female	43	46.24
Effective	55	36.18	47±0.5	Male	25	45.45
				Female	30	54.55
Ineffective	4	2.63	65±0.5	Male	3	0.75
				Female	1	0.25

Notes: ^aThere is statistical difference in age among all treatment groups (F=1.501, P<0.05); ^bThere is no statistical difference among all curative effect groups (X²=1.877, P>0.05).

Table 4 Comparison of Clinical Curative Effect of the COVID-19 Patients with Different Extrapulmonary Complications

	Number of Total Cases	Cured	Improved	Ineffective
Digestive system damage	98	79	15	4
Cardiovascular system damage	43	28	11	4
Urinary system damage	32	19	10	3
Nervous system damage	25	20	4	1

Notes: The difference in the clinical curative effect of COVID-19 patients with different extrapulmonary complications was not statistically significant (X²=8.154, P<0.05).